These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 37310587)

  • 1. Novel molecular mechanisms of doxorubicin cardiotoxicity: latest leading-edge advances and clinical implications.
    Robert Li Y; Traore K; Zhu H
    Mol Cell Biochem; 2024 May; 479(5):1121-1132. PubMed ID: 37310587
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Bach1/HO-1 pathway regulates oxidative stress and contributes to ferroptosis in doxorubicin-induced cardiomyopathy in H9c2 cells and mice.
    Wang Y; Qiu J; Yan H; Zhang N; Gao S; Xu N; Wang C; Lou H
    Arch Toxicol; 2024 Jun; 98(6):1781-1794. PubMed ID: 38573338
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Therapeutic Targets for DOX-Induced Cardiomyopathy: Role of Apoptosis vs. Ferroptosis.
    Kitakata H; Endo J; Ikura H; Moriyama H; Shirakawa K; Katsumata Y; Sano M
    Int J Mol Sci; 2022 Jan; 23(3):. PubMed ID: 35163335
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of METTL3 ameliorates doxorubicin-induced cardiotoxicity through suppression of TFRC-mediated ferroptosis.
    Wu L; Du Y; Wang L; Zhang Y; Ren J
    Redox Biol; 2024 Jun; 72():103157. PubMed ID: 38631119
    [TBL] [Abstract][Full Text] [Related]  

  • 5. LCZ696 protects against doxorubicin-induced cardiotoxicity by inhibiting ferroptosis via AKT/SIRT3/SOD2 signaling pathway activation.
    Liu X; Li D; Pi W; Wang B; Xu S; Yu L; Yao L; Sun Z; Jiang J; Mi Y
    Int Immunopharmacol; 2022 Dec; 113(Pt A):109379. PubMed ID: 36330913
    [TBL] [Abstract][Full Text] [Related]  

  • 6. WGX50 mitigates doxorubicin-induced cardiotoxicity through inhibition of mitochondrial ROS and ferroptosis.
    Tai P; Chen X; Jia G; Chen G; Gong L; Cheng Y; Li Z; Wang H; Chen A; Zhang G; Zhu Y; Xiao M; Wang Z; Liu Y; Shan D; He D; Li M; Zhan T; Khan A; Li X; Zeng X; Li C; Ouyang D; Ai K; Chen X; Liu D; Liu Z; Wei D; Cao K
    J Transl Med; 2023 Nov; 21(1):823. PubMed ID: 37978379
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lapatinib induces mitochondrial dysfunction to enhance oxidative stress and ferroptosis in doxorubicin-induced cardiomyocytes via inhibition of PI3K/AKT signaling pathway.
    Sun L; Wang H; Xu D; Yu S; Zhang L; Li X
    Bioengineered; 2022 Jan; 13(1):48-60. PubMed ID: 34898356
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Understanding the Protective Role of Exosomes in Doxorubicin-Induced Cardiotoxicity.
    Zhang G; Yang X; Su X; An N; Yang F; Li X; Jiang Y; Xing Y
    Oxid Med Cell Longev; 2022; 2022():2852251. PubMed ID: 36132225
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mitochondria-dependent ferroptosis plays a pivotal role in doxorubicin cardiotoxicity.
    Tadokoro T; Ikeda M; Ide T; Deguchi H; Ikeda S; Okabe K; Ishikita A; Matsushima S; Koumura T; Yamada KI; Imai H; Tsutsui H
    JCI Insight; 2020 May; 5(9):. PubMed ID: 32376803
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ethoxyquin is a Competent Radical-Trapping Antioxidant for Preventing Ferroptosis in Doxorubicin Cardiotoxicity.
    Tadokoro T; Ikeda M; Abe K; Ide T; Miyamoto HD; Furusawa S; Ishimaru K; Watanabe M; Ishikita A; Matsushima S; Koumura T; Yamada KI; Imai H; Tsutsui H
    J Cardiovasc Pharmacol; 2022 Nov; 80(5):690-699. PubMed ID: 35881422
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Doxorubicin causes ferroptosis and cardiotoxicity by intercalating into mitochondrial DNA and disrupting Alas1-dependent heme synthesis.
    Abe K; Ikeda M; Ide T; Tadokoro T; Miyamoto HD; Furusawa S; Tsutsui Y; Miyake R; Ishimaru K; Watanabe M; Matsushima S; Koumura T; Yamada KI; Imai H; Tsutsui H
    Sci Signal; 2022 Nov; 15(758):eabn8017. PubMed ID: 36318618
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Doxorubicin-induced cardiotoxicity: An update on the molecular mechanism and novel therapeutic strategies for effective management.
    Rawat PS; Jaiswal A; Khurana A; Bhatti JS; Navik U
    Biomed Pharmacother; 2021 Jul; 139():111708. PubMed ID: 34243633
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glycyrrhizin improved autophagy flux via HMGB1-dependent Akt/mTOR signaling pathway to prevent Doxorubicin-induced cardiotoxicity.
    Lv X; Zhu Y; Deng Y; Zhang S; Zhang Q; Zhao B; Li G
    Toxicology; 2020 Aug; 441():152508. PubMed ID: 32525084
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeting the Na
    Leng B; Deng L; Tan J; Lee WT; Cao CR; Wang ZP; Huang DJ; Nie X; Bian JS
    Free Radic Biol Med; 2023 Aug; 204():38-53. PubMed ID: 37100355
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endurance exercise preconditioning alleviates ferroptosis induced by doxorubicin-induced cardiotoxicity through mitochondrial superoxide-dependent AMPKα2 activation.
    Wang L; Qiao Y; Yu J; Wang Q; Wu X; Cao Q; Zhang Z; Feng Z; He H
    Redox Biol; 2024 Apr; 70():103079. PubMed ID: 38359747
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tanshinone I inhibits doxorubicin-induced cardiotoxicity by regulating Nrf2 signaling pathway.
    Jiang Q; Chen X; Tian X; Zhang J; Xue S; Jiang Y; Liu T; Wang X; Sun Q; Hong Y; Li C; Guo D; Wang Y; Wang Q
    Phytomedicine; 2022 Nov; 106():154439. PubMed ID: 36108374
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protective Role of Dioscin against Doxorubicin-Induced Chronic Cardiotoxicity: Insights from Nrf2-GPX4 Axis-Mediated Cardiac Ferroptosis.
    Liu J; Liu H; Deng L; Wang T; Li L; Chen Y; Qu L; Zou W
    Biomolecules; 2024 Mar; 14(4):. PubMed ID: 38672439
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Underlying the Mechanisms of Doxorubicin-Induced Acute Cardiotoxicity: Oxidative Stress and Cell Death.
    Kong CY; Guo Z; Song P; Zhang X; Yuan YP; Teng T; Yan L; Tang QZ
    Int J Biol Sci; 2022; 18(2):760-770. PubMed ID: 35002523
    [TBL] [Abstract][Full Text] [Related]  

  • 19. FTO ameliorates doxorubicin-induced cardiotoxicity by inhibiting ferroptosis via P53-P21/Nrf2 activation in a HuR-dependent m6A manner.
    Yang Y; Ren J; Zhang J; Shi H; Wang J; Yan Y
    Redox Biol; 2024 Apr; 70():103067. PubMed ID: 38316068
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An update of the molecular mechanisms underlying doxorubicin plus trastuzumab induced cardiotoxicity.
    Anjos M; Fontes-Oliveira M; Costa VM; Santos M; Ferreira R
    Life Sci; 2021 Sep; 280():119760. PubMed ID: 34166713
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.